COVID-19 Impact on Huntington's Disease Treatment Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Huntington's Disease Treatment Industry
1.7 COVID-19 Impact: Huntington's Disease Treatment Market Trends
2 Global Huntington's Disease Treatment Quarterly Market Size Analysis
2.1 Huntington's Disease Treatment Business Impact Assessment - COVID-19
2.1.1 Global Huntington's Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Huntington's Disease Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Huntington's Disease Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Huntington's Disease Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Huntington's Disease Treatment Market
3.4 Key Players Huntington's Disease Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Huntington's Disease Treatment Segments, By Type
4.1 Introduction
1.4.1 Symptomatic Therapy
1.4.2 Disease-Modifying Therapy
4.2 By Type, Global Huntington's Disease Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Huntington's Disease Treatment Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Ambulatory Surgical Centers
5.2 By Application, Global Huntington's Disease Treatment Market Size, 2019-2021
5.2.1 By Application, Global Huntington's Disease Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Bausch Health
7.1.1 Bausch Health Business Overview
7.1.2 Bausch Health Huntington's Disease Treatment Quarterly Revenue, 2020
7.1.3 Bausch Health Huntington's Disease Treatment Product Introduction
7.1.4 Bausch Health Response to COVID-19 and Related Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Business Overview
7.2.2 Teva Pharmaceuticals Huntington's Disease Treatment Quarterly Revenue, 2020
7.2.3 Teva Pharmaceuticals Huntington's Disease Treatment Product Introduction
7.2.4 Teva Pharmaceuticals Response to COVID-19 and Related Developments
7.3 Wave Life Sciences
7.3.1 Wave Life Sciences Business Overview
7.3.2 Wave Life Sciences Huntington's Disease Treatment Quarterly Revenue, 2020
7.3.3 Wave Life Sciences Huntington's Disease Treatment Product Introduction
7.3.4 Wave Life Sciences Response to COVID-19 and Related Developments
7.4 Ionis Pharmaceuticals/ Roche
7.4.1 Ionis Pharmaceuticals/ Roche Business Overview
7.4.2 Ionis Pharmaceuticals/ Roche Huntington's Disease Treatment Quarterly Revenue, 2020
7.4.3 Ionis Pharmaceuticals/ Roche Huntington's Disease Treatment Product Introduction
7.4.4 Ionis Pharmaceuticals/ Roche Response to COVID-19 and Related Developments
7.5 Raptor Pharmaceuticals
7.5.1 Raptor Pharmaceuticals Business Overview
7.5.2 Raptor Pharmaceuticals Huntington's Disease Treatment Quarterly Revenue, 2020
7.5.3 Raptor Pharmaceuticals Huntington's Disease Treatment Product Introduction
7.5.4 Raptor Pharmaceuticals Response to COVID-19 and Related Developments
7.6 Prana Biotechnology
7.6.1 Prana Biotechnology Business Overview
7.6.2 Prana Biotechnology Huntington's Disease Treatment Quarterly Revenue, 2020
7.6.3 Prana Biotechnology Huntington's Disease Treatment Product Introduction
7.6.4 Prana Biotechnology Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Huntington's Disease Treatment Assessment
Table 9. COVID-19 Impact: Huntington's Disease Treatment Market Trends
Table 10. COVID-19 Impact Global Huntington's Disease Treatment Market Size
Table 11. Global Huntington's Disease Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Huntington's Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Huntington's Disease Treatment Market Growth Drivers
Table 14. Global Huntington's Disease Treatment Market Restraints
Table 15. Global Huntington's Disease Treatment Market Opportunities
Table 16. Global Huntington's Disease Treatment Market Challenges
Table 17. By Players, Huntington's Disease Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Huntington's Disease Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Huntington's Disease Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Huntington's Disease Treatment Market
Table 21. Key Players Huntington's Disease Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Huntington's Disease Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Huntington's Disease Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Huntington's Disease Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Huntington's Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Bausch Health Business Overview
Table 58. Bausch Health Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bausch Health Huntington's Disease Treatment Product
Table 60. Bausch Health Response to COVID-19 and Related Developments
Table 61. Teva Pharmaceuticals Business Overview
Table 62. Teva Pharmaceuticals Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Teva Pharmaceuticals Huntington's Disease Treatment Product
Table 64. Teva Pharmaceuticals Response to COVID-19 and Related Developments
Table 65. Wave Life Sciences Business Overview
Table 66. Wave Life Sciences Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Wave Life Sciences Huntington's Disease Treatment Product
Table 68. Wave Life Sciences Response to COVID-19 and Related Developments
Table 69. Ionis Pharmaceuticals/ Roche Business Overview
Table 70. Ionis Pharmaceuticals/ Roche Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Ionis Pharmaceuticals/ Roche Huntington's Disease Treatment Product
Table 72. Ionis Pharmaceuticals/ Roche Response to COVID-19 and Related Developments
Table 73. Raptor Pharmaceuticals Business Overview
Table 74. Raptor Pharmaceuticals Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Raptor Pharmaceuticals Huntington's Disease Treatment Product
Table 76. Raptor Pharmaceuticals Response to COVID-19 and Related Developments
Table 77. Prana Biotechnology Business Overview
Table 78. Prana Biotechnology Huntington's Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Prana Biotechnology Huntington's Disease Treatment Product
Table 80. Prana Biotechnology Response to COVID-19 and Related Developments
List of FiguresFigure 1. Huntington's Disease Treatment Product Picture
Figure 2. Huntington's Disease Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Huntington's Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Huntington's Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Huntington's Disease Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Huntington's Disease Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Huntington's Disease Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Huntington's Disease Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Huntington's Disease Treatment Market Size Market Share, 2019-2021